- Senior Investigator, Cancer and Inflammation Program
Dr. Oppenheim obtained his M.D. degree from the Columbia College of Physicians and Surgeons, New York, trained as a clinical associate at the National Cancer Institute (NCI), Bethesda, Maryland, and was a postdoctoral fellow at the University of Birmingham, England, in immunology. He returned to the National Institute of Dental Research and subsequently headed the Section of Cellular Immunology there and, since 1983, has been head of the Laboratory of Molecular Immunoregulation, NCI-Frederick.
- (2018). HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Frontiers in Immunology. 9,
- (2018). High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin. SEMINARS IN IMMUNOLOGY. 38(C), 49-53.
- (2018). The Future of the Cytokine Discipline. Cold Spring Harbor Perspectives in Biology. 10(9),
- (2017). A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity. Journal of Innate Immunity. 9(5), 456-463.